MD (Pediatrix Medical Group) Cyclically Adjusted Revenue per Share: $29.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MD Pediatrix Medical Group Inc MD
50 GF Score
Price $26.11
GF Value $13.61
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pediatrix Medical Group Cyclically Adjusted Revenue per Share?

Pediatrix Medical Group MD -3.58% 50 Cyclically Adjusted Revenue per Share is $29.99 as of Jun. 2026. GuruFocus rates MD with a GF Score™ of 50/100 and a GF Value™ of $13.61 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Pediatrix Medical Group's adjusted revenue per share for the three months ended in Jun. 2026 was $5.992. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $29.99 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Pediatrix Medical Group's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Pediatrix Medical Group was 18.60% per year. The lowest was -0.30% per year. And the median was 14.65% per year.

As of today (2026-08-10), Pediatrix Medical Group's current stock price is $26.11. Pediatrix Medical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $29.99. Pediatrix Medical Group's Cyclically Adjusted PS Ratio of today is 0.87.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Pediatrix Medical Group was 3.54. The lowest was 0.22. And the median was 0.79.


Pediatrix Medical Group  (NYSE:MD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pediatrix Medical Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=26.11/29.99
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Pediatrix Medical Group was 3.54. The lowest was 0.22. And the median was 0.79.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Pediatrix Medical Group Cyclically Adjusted Revenue per Share Related Terms


Pediatrix Medical Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group Cyclically Adjusted Revenue per Share Chart

Pediatrix Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.57 30.43 31.07 31.13 30.17

Pediatrix Medical Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.01 30.75 30.17 30.20 29.99

MD vs ADUS, AVAH, SGRY: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's Cyclically Adjusted PS Ratio falls into.


MD
50GF Score
Pediatrix Medical Group Inc MD
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pediatrix Medical Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pediatrix Medical Group's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.992/333.9520*333.9520
=5.992

Current CPI (Jun. 2026) = 333.9520.

Pediatrix Medical Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 8.889 241.428 12.296
201612 8.904 241.432 12.316
201703 8.971 243.801 12.288
201706 9.082 244.955 12.382
201709 9.356 246.819 12.659
201712 7.607 246.524 10.305
201803 9.119 249.554 12.203
201806 9.248 251.989 12.256
201809 9.290 252.439 12.290
201812 -9.567 251.233 -12.717
201903 9.835 254.202 12.921
201906 6.706 256.143 8.743
201909 5.489 256.759 7.139
201912 5.516 256.974 7.168
202003 5.329 258.115 6.895
202006 4.961 257.797 6.427
202009 5.493 260.280 7.048
202012 4.972 260.474 6.375
202103 5.226 264.877 6.589
202106 5.504 271.696 6.765
202109 5.726 274.310 6.971
202112 5.795 278.802 6.941
202203 5.646 287.504 6.558
202206 5.677 296.311 6.398
202209 5.919 296.808 6.660
202212 6.265 296.797 7.049
202303 5.965 301.836 6.600
202306 6.056 305.109 6.628
202309 6.107 307.789 6.626
202312 6.023 306.746 6.557
202403 5.945 312.332 6.357
202406 6.052 314.175 6.433
202409 6.048 315.301 6.406
202412 6.005 315.605 6.354
202503 5.365 319.799 5.602
202506 5.482 322.561 5.676
202509 5.757 324.800 5.919
202512 5.851 324.054 6.030
202603 5.732 330.213 5.797
202606 5.992 333.952 5.992

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $29.99 mean?
Pediatrix Medical Group (MD) has a Cyclically Adjusted Revenue per Share of $29.99 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Pediatrix Medical Group and its competitors.
Is Pediatrix Medical Group's Cyclically Adjusted Revenue per Share too high?
Pediatrix Medical Group's current Cyclically Adjusted Revenue per Share is $29.99. Overall, Pediatrix Medical Group has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Cyclically Adjusted Revenue per Share compare to ADUS and AVAH?
Pediatrix Medical Group's Cyclically Adjusted Revenue per Share of $29.99 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Pediatrix Medical Group and its competitors. Pediatrix Medical Group's current Cyclically Adjusted Revenue per Share is $29.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (MD) is currently considered Significantly Overvalued. The stock's GF Value™ is $13.61, compared to a current price of $26.11 — trading 91.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $29.99. Pediatrix Medical Group's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Pediatrix Medical Group (MD), the current Cyclically Adjusted Revenue per Share is $29.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (MD) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of $26.11 is trading 91.8% above its estimated GF Value™ of $13.61. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for MD:

  • Cyclically Adjusted Revenue per Share: $29.99
  • GF Value™: $13.61 vs. price of $26.11 (91.8% above fair value)
  • GF Score™: 50/100 with 8 warning signs

No single metric tells the full story. See the MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pediatrix Medical Group Business Description

Other Exchanges PDC:Germany
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
50GF Score

Get the complete analysis for MD

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.11
Price
$13.61
GF Value